127 related articles for article (PubMed ID: 23321841)
1. Contrast dose, temporal footprint, and spatial resolution tradeoffs in dynamic contrast-enhanced MRA performed in a porcine model of a carotid aneurysm.
Ai T; Goerner F; Patel N; Trelles M; Wu G; Li X; Runge VM
J Comput Assist Tomogr; 2013; 37(1):105-10. PubMed ID: 23321841
[TBL] [Abstract][Full Text] [Related]
2. MR angiography of carotid artery aneurysms in a porcine model at 3 Tesla: comparison of two different macrocyclic gadolinium chelates and of dynamic and conventional techniques.
Wuesten O; Morelli JN; Miller MW; Tuzun E; Lenox MW; Fossum TW; Trelles M; Cotes C; Krombach GA; Runge VM
J Magn Reson Imaging; 2012 Nov; 36(5):1203-12. PubMed ID: 22826184
[TBL] [Abstract][Full Text] [Related]
3. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.
Voth M; Haneder S; Huck K; Gutfleisch A; Schönberg SO; Michaely HJ
Invest Radiol; 2009 Sep; 44(9):627-33. PubMed ID: 19652610
[TBL] [Abstract][Full Text] [Related]
4. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs.
Hadizadeh DR; Jost G; Pietsch H; Weibrecht M; Perkuhn M; Boschewitz JM; Keil VC; Träber F; Kukuk GM; Schild HH; Willinek WA
Invest Radiol; 2014 Jul; 49(7):457-64. PubMed ID: 24598442
[TBL] [Abstract][Full Text] [Related]
5. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine.
Fink C; Bock M; Kiessling F; Lichy MP; Krissak R; Zuna I; Schmähl A; Delorme S; Kauczor HU
J Magn Reson Imaging; 2004 Feb; 19(2):202-8. PubMed ID: 14745754
[TBL] [Abstract][Full Text] [Related]
6. Time-resolved MR angiography of renal artery stenosis in a swine model at 3 Tesla using gadobutrol with digital subtraction angiography correlation.
Morelli JN; Ai F; Runge VM; Zhang W; Li X; Schmitt P; McNeal G; Michaely HJ; Schoenberg SO; Miller M; Gerdes CM; Sincleair ST; Spratt H; Attenberger UI
J Magn Reson Imaging; 2012 Sep; 36(3):704-13. PubMed ID: 22645046
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance evaluation of renal artery stenosis in a swine model: performance of low-dose gadobutrol versus gadoterate meglumine in comparison with digital subtraction intra-arterial catheter angiography.
Morelli JN; Runge VM; Ai F; Zhang W; Li X; Schmitt P; McNeal G; Miller M; Lennox M; Wusten O; Schoenberg SO; Attenberger UI
Invest Radiol; 2012 Jun; 47(6):376-82. PubMed ID: 22543971
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 0.5-M Gd-DTPA with 1.0-M gadobutrol for magnetic resonance angiography of the supplying arteries of the spinal cord in thoracoabdominal aortic aneurysm patients.
Nijenhuis RJ; Gerretsen S; Leiner T; Jacobs MJ; van Engelshoven JM; Backes WH
J Magn Reson Imaging; 2005 Jul; 22(1):136-44. PubMed ID: 15971172
[TBL] [Abstract][Full Text] [Related]
9. 3.0 Tesla high spatial resolution contrast-enhanced magnetic resonance angiography (CE-MRA) of the pulmonary circulation: initial experience with a 32-channel phased array coil using a high relaxivity contrast agent.
Nael K; Fenchel M; Krishnam M; Finn JP; Laub G; Ruehm SG
Invest Radiol; 2007 Jun; 42(6):392-8. PubMed ID: 17507810
[TBL] [Abstract][Full Text] [Related]
10. Using a 1 M Gd-chelate (gadobutrol) for total-body three-dimensional MR angiography: preliminary experience.
Goyen M; Herborn CU; Vogt FM; Kröger K; Verhagen R; Yang F; Bosk S; Debatin JF; Ruehm SG
J Magn Reson Imaging; 2003 May; 17(5):565-71. PubMed ID: 12720266
[TBL] [Abstract][Full Text] [Related]
11. Supraaortic arteries: contrast material dose reduction at 3.0-T high-spatial-resolution MR angiography--feasibility study.
Tomasian A; Salamon N; Lohan DG; Jalili M; Villablanca JP; Finn JP
Radiology; 2008 Dec; 249(3):980-90. PubMed ID: 19011192
[TBL] [Abstract][Full Text] [Related]
12. Qualitative and quantitative analysis of routinely postprocessed (CLEAR) CE-MRA data sets: are SNR and CNR calculations reliable?
Buerke B; Allkemper T; Kugel H; Bremer C; Evers S; Kooijman H; Heindel W; Tombach B
Acad Radiol; 2008 Sep; 15(9):1111-7. PubMed ID: 18692751
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Power Versus Manual Injection in Bolus Shape and Image Quality on Contrast-Enhanced Magnetic Resonance Angiography: An Experimental Study in a Swine Model.
Tsuboyama T; Jost G; Pietsch H; Tomiyama N
Invest Radiol; 2017 Sep; 52(9):547-553. PubMed ID: 28448310
[TBL] [Abstract][Full Text] [Related]
14. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in cardiac and vascular diseases: correlation to high spatial resolution 3D contrast-enhanced MRA.
Krishnam MS; Tomasian A; Lohan DG; Tran L; Finn JP; Ruehm SG
Clin Radiol; 2008 Jul; 63(7):744-55. PubMed ID: 18555032
[TBL] [Abstract][Full Text] [Related]
15. High spatial-resolution CE-MRA of the carotid circulation with parallel imaging: comparison of image quality between 2 different acceleration factors at 3.0 Tesla.
Nael K; Ruehm SG; Michaely HJ; Pope W; Laub G; Finn JP; Villablanca JP
Invest Radiol; 2006 Apr; 41(4):391-9. PubMed ID: 16523022
[TBL] [Abstract][Full Text] [Related]
16. High-resolution steady state magnetic resonance angiography of the carotid arteries: are intravascular agents necessary?: feasibility and preliminary experience with gadobenate dimeglumine.
Anzidei M; Napoli A; Marincola BC; Kirchin MA; Neira C; Geiger D; Zaccagna F; Catalano C; Passariello R
Invest Radiol; 2009 Dec; 44(12):784-92. PubMed ID: 19858728
[TBL] [Abstract][Full Text] [Related]
17. Noncontrast 3D steady-state free-precession magnetic resonance angiography of the whole chest using nonselective radiofrequency excitation over a large field of view: comparison with single-phase 3D contrast-enhanced magnetic resonance angiography.
Krishnam MS; Tomasian A; Deshpande V; Tran L; Laub G; Finn JP; Ruehm SG
Invest Radiol; 2008 Jun; 43(6):411-20. PubMed ID: 18496046
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced magnetic resonance angiography of the lower extremities: standard-dose vs. high-dose gadodiamide injection.
Krause U; Kroencke T; Spielhaupter E; Taupitz M; Kenn W; Hamm B; Hahn D
J Magn Reson Imaging; 2005 Apr; 21(4):449-54. PubMed ID: 15778953
[TBL] [Abstract][Full Text] [Related]
19. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla.
Kramer U; Fenchel M; Laub G; Seeger A; Klumpp B; Bretschneider C; Finn JP; Claussen CD; Miller S
Acad Radiol; 2010 May; 17(5):564-76. PubMed ID: 20171907
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced magnetic resonance angiography (MRA): evaluation of three different contrast agents at two different doses (0.05 and 0.1 mmol/kg) in pigs at 1.5 Tesla.
Voth M; Michaely HJ; Schwenke C; Vos B; Pietsch H
Eur Radiol; 2011 Feb; 21(2):337-44. PubMed ID: 20809127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
